Clinical trial
Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study
NCT05417139 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sintilimab Combined With Chemotherapy and Radiotherapy in Newly Diagnosed Metastatic Nasopharyngeal Carcinoma: A Multicenter Study
- Lead sponsor
- Sun Yat-sen University
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 1, 2022
- Completion date
- July 1, 2025
- Enrollment
- 43 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.